173 related articles for article (PubMed ID: 25418836)
1. Modeling the mitotic regulatory network identifies highly efficient anti-cancer drug combinations.
Wu Y; Zhuo X; Dai Z; Guo X; Wang Y; Zhang C; Lai L
Mol Biosyst; 2015 Feb; 11(2):497-505. PubMed ID: 25418836
[TBL] [Abstract][Full Text] [Related]
2. Co-inhibition of polo-like kinase 1 and Aurora kinases promotes mitotic catastrophe.
Li J; Hong MJ; Chow JP; Man WY; Mak JP; Ma HT; Poon RY
Oncotarget; 2015 Apr; 6(11):9327-40. PubMed ID: 25871386
[TBL] [Abstract][Full Text] [Related]
3. The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of polo-like kinase 1.
Lénárt P; Petronczki M; Steegmaier M; Di Fiore B; Lipp JJ; Hoffmann M; Rettig WJ; Kraut N; Peters JM
Curr Biol; 2007 Feb; 17(4):304-15. PubMed ID: 17291761
[TBL] [Abstract][Full Text] [Related]
4. Anti-mitotic therapies in cancer.
Tischer J; Gergely F
J Cell Biol; 2019 Jan; 218(1):10-11. PubMed ID: 30545842
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.
Spartà AM; Bressanin D; Chiarini F; Lonetti A; Cappellini A; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Martelli AM
Cell Cycle; 2014; 13(14):2237-47. PubMed ID: 24874015
[TBL] [Abstract][Full Text] [Related]
6. Integrated computational model of cell cycle and checkpoint reveals different essential roles of Aurora-A and Plk1 in mitotic entry.
Zou J; Luo SD; Wei YQ; Yang SY
Mol Biosyst; 2011 Jan; 7(1):169-79. PubMed ID: 20978655
[TBL] [Abstract][Full Text] [Related]
7. Global assessment of its network dynamics reveals that the kinase Plk1 inhibits the phosphatase PP6 to promote Aurora A activity.
Kettenbach AN; Schlosser KA; Lyons SP; Nasa I; Gui J; Adamo ME; Gerber SA
Sci Signal; 2018 May; 11(530):. PubMed ID: 29764989
[TBL] [Abstract][Full Text] [Related]
8. Polo and Aurora kinases: lessons derived from chemical biology.
Taylor S; Peters JM
Curr Opin Cell Biol; 2008 Feb; 20(1):77-84. PubMed ID: 18249108
[TBL] [Abstract][Full Text] [Related]
9. Stathmin and microtubules regulate mitotic entry in HeLa cells by controlling activation of both Aurora kinase A and Plk1.
Silva VC; Cassimeris L
Mol Biol Cell; 2013 Dec; 24(24):3819-31. PubMed ID: 24152729
[TBL] [Abstract][Full Text] [Related]
10. Non-mitotic functions of polo-like kinases in cancer cells.
Raab CA; Raab M; Becker S; Strebhardt K
Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188467. PubMed ID: 33171265
[TBL] [Abstract][Full Text] [Related]
11. Identification of green tea catechins as potent inhibitors of the polo-box domain of polo-like kinase 1.
Shan HM; Shi Y; Quan J
ChemMedChem; 2015 Jan; 10(1):158-63. PubMed ID: 25196850
[TBL] [Abstract][Full Text] [Related]
12. Biological impact of freezing Plk1 in its inactive conformation in cancer cells.
Keppner S; Proschak E; Kaufmann M; Strebhardt K; Schneider G; Spänkuch B
Cell Cycle; 2010 Feb; 9(4):761-73. PubMed ID: 20139717
[TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 1 is essential for the first mitotic division in the mouse embryo.
Baran V; Solc P; Kovarikova V; Rehak P; Sutovsky P
Mol Reprod Dev; 2013 Jul; 80(7):522-34. PubMed ID: 23649868
[TBL] [Abstract][Full Text] [Related]
14. Phosphatase 1 Nuclear Targeting Subunit (PNUTS) Regulates Aurora Kinases and Mitotic Progression.
Wang F; Wang L; Fisher LA; Li C; Wang W; Peng A
Mol Cancer Res; 2019 Jan; 17(1):10-19. PubMed ID: 30190438
[TBL] [Abstract][Full Text] [Related]
15. Polo-like kinase controls vertebrate spindle elongation and cytokinesis.
Brennan IM; Peters U; Kapoor TM; Straight AF
PLoS One; 2007 May; 2(5):e409. PubMed ID: 17476331
[TBL] [Abstract][Full Text] [Related]
16. Distinct concentration-dependent effects of the polo-like kinase 1-specific inhibitor GSK461364A, including differential effect on apoptosis.
Gilmartin AG; Bleam MR; Richter MC; Erskine SG; Kruger RG; Madden L; Hassler DF; Smith GK; Gontarek RR; Courtney MP; Sutton D; Diamond MA; Jackson JR; Laquerre SG
Cancer Res; 2009 Sep; 69(17):6969-77. PubMed ID: 19690138
[TBL] [Abstract][Full Text] [Related]
17. Polo-like kinase 1 inhibitor BI2536 causes mitotic catastrophe following activation of the spindle assembly checkpoint in non-small cell lung cancer cells.
Choi M; Kim W; Cheon MG; Lee CW; Kim JE
Cancer Lett; 2015 Feb; 357(2):591-601. PubMed ID: 25524551
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of polo-like kinase 1 suppresses microtubule dynamics in MCF-7 cells.
Rashid A; Naaz A; Rai A; Chatterji BP; Panda D
Mol Cell Biochem; 2020 Feb; 465(1-2):27-36. PubMed ID: 31782084
[TBL] [Abstract][Full Text] [Related]
19. The vanillin derivative 6-bromine-5-hydroxy-4-methoxybenzaldehyde induces aberrant mitotic progression and enhances radio-sensitivity accompanying suppression the expression of PLK1 in esophageal squamous cell carcinoma.
Gu MM; Li M; Gao D; Liu LH; Lang Y; Yang SM; Ou H; Huang B; Zhou PK; Shang ZF
Toxicol Appl Pharmacol; 2018 Jun; 348():76-84. PubMed ID: 29679654
[TBL] [Abstract][Full Text] [Related]
20. Purification and proteomic identification of putative upstream regulators of polo-like kinase-1 from mitotic cell extracts.
Ji JH; Hwang HI; Lee HJ; Hyun SY; Kang HJ; Jang YJ
FEBS Lett; 2010 Oct; 584(20):4299-305. PubMed ID: 20869364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
